ReceptoPharm  
Home   Drug Development   CRO Services   Newsroom   About ReceptoPharm   Contact
» Recent News
» Archives
» E-Alerts
 
Drug Development

ReceptoPharm is developing proprietary therapeutic protein products for the treatment of neurological, viral and and autoimmune disorders.

» Learn More
 
CRO Services

ReceptoPharm offers a full range of contract research services catering to small and start-up biotech companies.

» Learn More

Newsroom

Below you will find the most recent ReceptoPharm press releases. To view press releases from previous years, please visit the Archives.

Recent News

November 05, 2010
Nutra Pharma Awarded Grant under the Qualifying Therapeutic Discovery Project Program


October 26, 2010
Nutra Pharma Selects Nutritional Alliance as its Global Sales Agent


September 27, 2010
Nutra Pharma Introduces Nyloxin for Pets - a Treatment for Moderate to Severe Chronic Pain in Companion Animals


September 14, 2010
Nutra Pharma Amends Cobroxin Distribution Agreement with XenaCare Holdings


August 19, 2010
Nutra Pharma Begins Drug Registration Process in India for Nyloxin - a Treatment for Moderate to Severe Chronic Pain


August 09, 2010
Nutra Pharma Announces Amarey Nova Medical as its Exclusive Nyloxin Distributor in Colombia


August 06, 2010
Nutra Pharma Announces Second Quarter 2010 Sales and Distribution Update


July 28, 2010
Nutra Pharma Receives Patent for Novel Antiviral Treatment using Modified Cobra Venom


July 22, 2010
Nutra Pharma Drug Discovery Subsidiary to Introduce Novel Antiviral Therapy at the International AIDS Conference in Vienna, Austria


June 23, 2010
Nutra Pharma Begins Drug Registration Process in Central America for its Nyloxin Pain Reliever


Recent News
November 05, 2010
Nutra Pharma Awarded Grant under the Qualifying Therapeutic Discovery Project Program
 
E-Alerts
Signup to receive news and announcements from ReceptoPharm and Nutra Pharma:
First Name:
Last Name:
Email:
NPC